| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| Gene symbol | TNFRSF8 | Synonyms | CD30, D1S166E, Ki-1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p36.22 | dbXrefs | |
| Description | TNF receptor superfamily member 8 | ||||
| GTO ID | GTC0610 |
| Trial ID | ChiCTR2000028922 |
| Disease | Hodgkin's Lymphoma |
| Altered gene | CD19|CD30 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19/CD30 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | CD19 and CD30 CAR-T Cells Immunotherapy for Relapsing/Refractory Hodgkin's Lymphoma Patient: single center, single arm, open clinical study |
| Year | 2020 |
| Country | China |
| Company sponsor | The Third Affiliated Hospital of Kunming Medical University |
| Cohort 1 | |||||||||||||||||
|
|||||||||||||||||